Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial

We evaluated the efficacy of the human papillomavirus (HPV)−16/18 AS04‐adjuvanted vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc analysis of the PApilloma TRIal against Cancer In young Adults (PATRICIA; NCT00122681). Healthy women aged 15–25 years were ran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Garland, Suzanne M., Paavonen, Jorma, Jaisamrarn, Unnop, Naud, Paulo, Salmerón, Jorge, Chow, Song‐Nan, Apter, Dan, Castellsagué, Xavier, Teixeira, Júlio C., Skinner, S. Rachel, Hedrick, James, Limson, Genara, Schwarz, Tino F., Poppe, Willy A.J., Bosch, F. Xavier, de Carvalho, Newton S., Germar, Maria Julieta V., Peters, Klaus, Del Rosario‐Raymundo, M. Rowena, Catteau, Grégory, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Cancer Therapy and Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412942/
https://ncbi.nlm.nih.gov/pubmed/27541373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados